Centre d'Etudes et de Recherches en Santé publique
0423.434.989 · rovalta.com · 28/09/2026
Centre d'Etudes et de Recherches en Santé publique
Company — Normal situation.
Financial year 2021 · Closed on 31/12/2021
Overview
Identity
Source · BCE/KBOCentre d'Etudes et de Recherches en Santé publique is a company registered in Belgium. It employs on average 0,1 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0423.434.989
- Legal form
- Non-profit organization
- Latest accounts
- 31/12/2021
- Average workforce
- 0,1 ETP
Financials
Source · NBB, 11 filingsTrend over 10 financial years
| 2021 | 2015 | 2014 | 2013 | 2012 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -59 k € | -221% | 48,8 k € | +1110% | 4 k € | -98.3% | 235,6 k € | +56.9% | 150,1 k € |
| EBITDA | -70,8 k € | -934% | -6,9 k € | +93.5% | -105,3 k € | -169% | 152 k € | +1627% | -10 k € |
| Operating result | -71,5 k € | -316% | -17,2 k € | +85.0% | -114,8 k € | -183% | 138,7 k € | +682% | -23,8 k € |
| Net result | -63,3 k € | -561% | -9,6 k € | +91.5% | -112,6 k € | -176% | 147,8 k € | +971% | -17 k € |
| Balance sheet | |||||||||
| Equity | 81,1 k € | -84.5% | 523,3 k € | -1.8% | 532,9 k € | -17.4% | 645,5 k € | +29.7% | 497,7 k € |
| Total assets | 87,1 k € | -85.1% | 585 k € | -1.2% | 592,3 k € | -15.5% | 700,5 k € | +24.2% | 564 k € |
| Cash | 31,6 k € | -59.3% | 77,7 k € | -56.2% | 177,3 k € | -33.6% | 267,1 k € | +71.2% | 156 k € |
| Debts | 6 k € | -86.6% | 44,8 k € | -24.5% | 59,4 k € | +7.9% | 55,1 k € | -16.0% | 65,6 k € |
| Other | |||||||||
| Workforce | 0,1 ETP | -94.1% | 1,7 ETP | -19.0% | 2,1 ETP | -32.3% | 3,1 ETP | -42.6% | 5,4 ETP |
Board of directors
Source · NBB, accounts to 31/12/20218 active · 5 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Alain Leveque | Chairman of the board of directorssince 01/07/2016Vice-chairman of the board of directors09/05/2008 → 25/05/2010endedMandateendedDirectorended | ||
Jean-Pierre Rezette | Vice-chairman of the board of directorssince 01/07/2016 | ||
Catherine Bouland | Directorsince 14/06/2013 | ||
Béatrice Swennen | Mandatesince 09/05/2008Directoruntil 25/05/2010ended | ||
Claire Humblet | DirectorMandate09/05/2008 → 25/05/2010ended | ||
Raphaël Lagasse | Mandatesince 09/05/2008Directoruntil 25/05/2010ended | ||
France Kittel | DirectorMandate09/05/2008 → 09/05/2009ended | ||
Yves Coppieters | Director |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Bruno Dujardin | Mandate25/05/2009 → 25/05/2010 | ||
Christophe De Brouwer | Chairman of the board of directors25/05/2009 → 25/05/2010 | ||
Danielle Piette | Mandate25/05/2009 → 25/05/2010 | ||
France Kittel France | Mandate25/05/2009 → 25/05/2010 |
Financials
Full financial information
Source · NBB| 2021 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2021 | 01/01/2015 | 01/01/2014 | 01/01/2013 | 01/01/2012 | 01/01/2011 |
| Closing of the financial year | 31/12/2021 | 31/12/2015 | 31/12/2014 | 31/12/2013 | 31/12/2012 | 31/12/2011 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/06/2022 | 09/09/2016 | 08/07/2015 | 26/06/2014 | 26/06/2013 | 08/07/2012 |
| General meeting | 20/06/2022 | 01/07/2016 | 29/06/2015 | 19/06/2014 | 14/06/2013 | 04/07/2012 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 11 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2021 | 20/06/2022 | 29/06/2022 | French | |
| Abridged model | 31/12/2015 | 01/07/2016 | 09/09/2016 | French | |
| Abridged model | 31/12/2014 | 29/06/2015 | 08/07/2015 | French | |
| Abridged model | 31/12/2013 | 19/06/2014 | 26/06/2014 | French | |
| Abridged model | 31/12/2012 | 14/06/2013 | 26/06/2013 | French | |
| Abridged model | 31/12/2011 | 04/07/2012 | 08/07/2012 | French | |
| Abridged model | 31/12/2010 | 30/05/2011 | 23/08/2011 | French | |
| Abridged model | 31/12/2009 | 16/06/2010 | 10/09/2010 | French | |
| Abridged model | 31/12/2008 | 25/05/2009 | 17/06/2009 | French | |
| Abridged model | 31/12/2007 | 09/05/2008 | 20/06/2008 | French | |
| Abridged model | 31/12/2006 | 13/06/2007 | 25/07/2007 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20218 active · 5 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Alain Leveque | Chairman of the board of directorssince 01/07/2016Vice-chairman of the board of directors09/05/2008 → 25/05/2010endedMandateendedDirectorended | ||
Jean-Pierre Rezette | Vice-chairman of the board of directorssince 01/07/2016 | ||
Catherine Bouland | Directorsince 14/06/2013 | ||
Béatrice Swennen | Mandatesince 09/05/2008Directoruntil 25/05/2010ended | ||
Claire Humblet | DirectorMandate09/05/2008 → 25/05/2010ended | ||
Raphaël Lagasse | Mandatesince 09/05/2008Directoruntil 25/05/2010ended | ||
France Kittel | DirectorMandate09/05/2008 → 09/05/2009ended | ||
Yves Coppieters | Director |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Bruno Dujardin | Mandate25/05/2009 → 25/05/2010 | ||
Christophe De Brouwer | Chairman of the board of directors25/05/2009 → 25/05/2010 | ||
Danielle Piette | Mandate25/05/2009 → 25/05/2010 | ||
France Kittel France | Mandate25/05/2009 → 25/05/2010 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution04/01/2023RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
- Mandates08/09/2022DEMISSIONS, NOMINATIONS
- Mandates28/03/2017DEMISSIONS, NOMINATIONS
- Mandates19/01/2016DEMISSIONS, NOMINATIONS
- Mandates10/10/2013DEMISSIONS, NOMINATIONS
- Mandates13/10/2009DEMISSIONS, NOMINATIONS
- Mandates26/06/2008DEMISSIONS, NOMINATIONS
- Mandates08/12/2005DEMISSIONS, NOMINATIONS - CAPITAL, ACTIONS - DIVERS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Route de Lennik 808, 1070 Anderlecht | accounts 2021 | Accounts 2021 · 2022-20138853 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Centre d'Etudes et de Recherches en Santé publique | accounts 2021 | Accounts 2021 · 2022-20138853 |
Events
- 2021Annual accounts 2021-63,3 k €↓
- 2015Annual accounts 2015-9,6 k €↑
- 2014Annual accounts 2014-112,6 k €↓
- 2013Annual accounts 2013147,8 k €↑
- 2012Annual accounts 2012-17 k €↓
- 2011Annual accounts 20113,4 k €↑
- 2010Annual accounts 2010-2,9 k €↓
- 2009Annual accounts 200993,5 k €↑
- 2008Annual accounts 200893,3 k €↑
- 2007Annual accounts 2007-4,6 k €